Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents

• প্রধান লেখক: Yan Wang (লেখক), Yuanyuan Hu (লেখক), Ting Wang (লেখক), Guowei Che (লেখক), Lu Li (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background and purpose: Previous studies have found that metformin can inhibit tumor growth and improve outcomes for cancer patients. However, the association between the addition of metformin to the treatment regimen and survival in non-small cell lung cancer (NSCLC) patients receiving antineoplast...